NEWS & UPDATES
2022
Click to learn more on select titles
SAMANTHA AND VICTORIA RECEIVE AWARDS
December 14, 2022
Sam and Tori were recognized for "Exceptional Performance in Research and Teamwork" and "Innovation and Creativity in Research," respectively, by UCR's Division of Biomedical Sciences community
November 13, 2022
An article was published covering an interview with Dr. Ethell and Tori on the work covered in Tori's SFN poster
SAMANTHA AND VICTORIA PRESENT AT SOCIETY FOR NEUROSCIENCE
November 12, 2022
Sam and Tori presented their posters "Astrocytic ephrin-B1 regulates PV inhibitory synapse development in the CA1 hippocampus" and "Astrocytes dysregulate GABA expression and transmission in Fragile X Syndrome affecting cortical responses to sound," respectively, at the opening poster session for SfN.
VICTORIA PRESENTS AT THE INLAND EMPIRE STEM CELL CONSORTIUM
November 4, 2022
Dr. Ethell and Tori attend the IESCC where Tori presents a poster on the lovastatin project
ANNA AWARDED FRAXA FELLOWSHIP
October 10, 2022
Anna was awarded a FRAXA fellowship
SAMANTHA AWARDED F31
July 24, 2022
Sam has been officially offered an F31 fellowship for her project "Elucidating the role of astrocytic ephrin-B1 in inhibitory circuit development in the CA1 hippocampus." The Ethell lab and colleagues gathered to celebrate her achievement
STRIDE SYMPOSIUM
July 23, 2022
Congratulations to Gracie for graduating the STRIDE program. Gracie and Tori presented posters to the STRIDE and TRANSCEND students
STRIDE STUDENT JOINS THE LAB
June 21, 2022
Welcome to STRIDE mentee Gracie Le
The Summer Training and Research Inspiration for Diverse Pipeline Engagement toward Advancing Stem Cell Treatment (STRIDE) supports local high school students in developing science and communication skills, sponsored by CIRM
WELCOME SUMMER INTERNS
June 21, 2022
Rotating medical students Jasmin Regalado and Derek Breiner and summer intern Ryan Merchel join the lab
SAM PRESENTS AT CELL SYMPOSIA
May 17, 2022
Sam presents her poster at the Biology of Neuropsychiatric Disorders conference in Sitges, Spain
SAMANTHA RECEIVES F31 SUMMARY STATEMENT
March 3, 2022
Sam earned a promising score on her F31 application
VICTORIA SELECTED FOR A CIRM TRANSCEND FELLOWSHIP
March 3, 2022
Tori will start a 3 year fellowship through UCR's Stem Cell Training Program supported by the California Institute for Regenerative Medicine
2021
SAM PRESENTS AT ISNN 2021
October 22, 2021
Sam presented "The EPHects of Astrocytic Ephrin-B1 on Inhibitory Circuit Development in the CA1 Hippocampus" on the opening day of the International Symposium Networking in Neuroscience
NEW LAB MEMBER
September 22, 2021
Victoria Wagner joins the Ethell lab to study astrocytic cholesterol in Fragile X
Older
BRAIN PROTEIN LINKED TO SEIZURES AND ABNORMAL SOCIAL BEHAVIORS
August 31, 2020
A team led by a biomedical scientist at the University of California, Riverside has found a new mechanism responsible for the abnormal development of neuronal connections in the mouse brain that leads to seizures and abnormal social behaviors.
OFTEN OVERLOOKED GLIAL CELL IS KEY TO LEARNING AND MEMORY
June 18, 2018
Glial cells surround neurons and provide support -- not unlike hospital staff and nurses supporting doctors to keep operations running smoothly. These often-overlooked cells, which include oligodendrocytes and astrocytes, are the most abundant cell types in the central nervous system. But these cells do more than support neurons.
STUDY LEADER IRYNA ETHELL AWARDED FRAXA BREAKTHROUGH AWARD FOR 2008
October 4, 2008
A University of California Riverside team of scientists has found that an available drug called minocycline, used widely to treat acne and skin infections, might also be used to treat Fragile X. The study’s findings have already led to the approval of a FRAXA-funded clinical trial in Toronto, Canada, that will test minocycline in patients with Fragile X.